Allspring Global Investments Holdings LLC Sells 16,804 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Allspring Global Investments Holdings LLC cut its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 10.6% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 141,094 shares of the pharmacy operator’s stock after selling 16,804 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Walgreens Boots Alliance were worth $1,264,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Iron Horse Wealth Management LLC boosted its stake in Walgreens Boots Alliance by 162.5% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 1,300 shares during the last quarter. Blue Trust Inc. boosted its holdings in Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 1,081 shares during the last quarter. Continuum Advisory LLC lifted its position in Walgreens Boots Alliance by 71.2% during the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares in the last quarter. Strategic Investment Solutions Inc. IL acquired a new position in shares of Walgreens Boots Alliance during the 2nd quarter worth about $34,000. Finally, New Covenant Trust Company N.A. bought a new position in shares of Walgreens Boots Alliance in the 1st quarter valued at about $35,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

WBA opened at $9.46 on Friday. The firm has a market capitalization of $8.18 billion, a PE ratio of -0.95, a price-to-earnings-growth ratio of 1.20 and a beta of 0.70. The business’s 50-day moving average is $9.22 and its two-hundred day moving average is $12.57. Walgreens Boots Alliance, Inc. has a 1 year low of $8.22 and a 1 year high of $27.05. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The company had revenue of $37.50 billion during the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm’s quarterly revenue was up 5.9% on a year-over-year basis. During the same quarter last year, the business posted $0.67 EPS. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.54 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.57%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -9.99%.

Analyst Upgrades and Downgrades

WBA has been the topic of a number of recent analyst reports. TD Cowen decreased their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. JPMorgan Chase & Co. dropped their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Barclays lifted their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 16th. Evercore ISI increased their price target on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday, October 16th. Finally, Truist Financial reduced their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $12.88.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.